Literature DB >> 12186871

Charged amino acids in the sixth transmembrane helix of multidrug resistance protein 1 (MRP1/ABCC1) are critical determinants of transport activity.

Anass Haimeur1, Roger G Deeley, Susan P C Cole.   

Abstract

The multidrug resistance protein, MRP1 (ABCC1), is an ATP-binding cassette transporter that confers resistance to chemotherapeutic agents. MRP1 also mediates transport of organic anions such as leukotriene C(4) (LTC(4)), 17beta-estradiol 17-(beta-d-glucuronide) (E(2)17betaG), estrone 3-sulfate, methotrexate (MTX), and GSH. We replaced three charged amino acids, Lys(332), His(335), and Asp(336), predicted to be in the sixth transmembrane (TM6) helix of MRP1 with neutral and oppositely charged amino acids and determined the effect on substrate specificity and transport activity. All mutants were expressed in transfected human embryonic kidney cells at levels comparable with wild-type MRP1, and confocal microscopy showed that they were correctly routed to the plasma membrane. Vesicular transport studies revealed that the MRP1-Lys(332) mutants had lost the ability to transport LTC(4), and GSH transport was reduced; whereas E(2)17betaG, estrone 3-sulfate, and MTX transport were unaffected. E(2)17betaG transport was not inhibited by LTC(4) and could not be photolabeled with [(3)H]LTC(4), indicating that the MRP1-Lys(332) mutants no longer bound this substrate. Substitutions of MRP1-His(335) also selectively diminished LTC(4) transport and photolabeling but to a lesser extent. Kinetic analyses showed that V(max) (LTC(4)) of these mutants was decreased but K(m) was unchanged. In contrast to the selective loss of LTC(4) transport in the Lys(332) and His(335) mutants, the MRP1-Asp(336) mutants no longer transported LTC(4), E(2)17betaG, estrone 3-sulfate, or GSH, and transport of MTX was reduced by >50%. Lys(332), His(335), and Asp(336) of TM6 are predicted to be in the outer leaflet of the membrane and are all capable of forming intrahelical and interhelical ion pairs and hydrogen bonds. The importance of Lys(332) and His(335) in determining substrate specificity and of Asp(336) in overall transport activity suggests that such interactions are critical for the binding and transport of LTC(4) and other substrates of MRP1.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12186871     DOI: 10.1074/jbc.M206228200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  12 in total

1.  Role of the NH2-terminal membrane spanning domain of multidrug resistance protein 1/ABCC1 in protein processing and trafficking.

Authors:  Christopher J Westlake; Susan P C Cole; Roger G Deeley
Journal:  Mol Biol Cell       Date:  2005-03-16       Impact factor: 4.138

2.  Single Nanoparticle Plasmonic Spectroscopy for Study of Charge-Dependent Efflux Function of Multidrug ABC Transporters of Single Live Bacillus subtilis Cells.

Authors:  Lauren M Browning; Kerry J Lee; Prakash D Nallathamby; Pavan K Cherukuri; Tao Huang; Seth Warren; Xiao-Hong Nancy Xu
Journal:  J Phys Chem C Nanomater Interfaces       Date:  2016-05-26       Impact factor: 4.126

3.  Functional analysis of nonsynonymous single nucleotide polymorphisms of multidrug resistance-associated protein 2 (ABCC2).

Authors:  Vandana Megaraj; Tianyong Zhao; Christian M Paumi; Phillip M Gerk; Richard B Kim; Mary Vore
Journal:  Pharmacogenet Genomics       Date:  2011-08       Impact factor: 2.089

4.  Nucleotides and transported substrates modulate different steps of the ATPase catalytic cycle of MRP1 multidrug transporter.

Authors:  András Kern; Zsófia Szentpétery; Károly Liliom; Eva Bakos; Balázs Sarkadi; András Váradi
Journal:  Biochem J       Date:  2004-06-01       Impact factor: 3.857

Review 5.  Multidrug resistance protein 1 (MRP1, ABCC1), a "multitasking" ATP-binding cassette (ABC) transporter.

Authors:  Susan P C Cole
Journal:  J Biol Chem       Date:  2014-10-03       Impact factor: 5.157

6.  A region within a lumenal loop of Saccharomyces cerevisiae Ycf1p directs proteolytic processing and substrate specificity.

Authors:  Deborah L Mason; Monica P Mallampalli; Gregory Huyer; Susan Michaelis
Journal:  Eukaryot Cell       Date:  2003-06

7.  Structure of a human multidrug transporter in an inward-facing conformation.

Authors:  Mark F Rosenberg; Curtis J Oleschuk; Peng Wu; Qingcheng Mao; Roger G Deeley; Susan P C Cole; Robert C Ford
Journal:  J Struct Biol       Date:  2010-01-28       Impact factor: 2.867

8.  xCT, not just an amino-acid transporter: a multi-functional regulator of microbial infection and associated diseases.

Authors:  Lu Dai; Mairi C Noverr; Chris Parsons; Johnan A R Kaleeba; Zhiqiang Qin
Journal:  Front Microbiol       Date:  2015-02-19       Impact factor: 5.640

9.  Mutagenic Analysis of the Putative ABCC6 Substrate-Binding Cavity Using a New Homology Model.

Authors:  Flora Szeri; Valentina Corradi; Fatemeh Niaziorimi; Sylvia Donnelly; Gwenaëlle Conseil; Susan P C Cole; D Peter Tieleman; Koen van de Wetering
Journal:  Int J Mol Sci       Date:  2021-06-27       Impact factor: 5.923

10.  Targeting xCT, a cystine-glutamate transporter induces apoptosis and tumor regression for KSHV/HIV-associated lymphoma.

Authors:  Lu Dai; Yueyu Cao; Yihan Chen; Chris Parsons; Zhiqiang Qin
Journal:  J Hematol Oncol       Date:  2014-04-04       Impact factor: 17.388

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.